Cardinal Health, Inc.
Location
Ohio
Founded
1979-02-28
Website
Risk Signals
3280 news mentions monitored
Industry Context
This company is tracked across risk categories, including those related to its sector (e.g., Medical, Dental, and Hospital Equipment and Supplies, Drugs, Drug Proprietaries, and Druggists' Sundries, Management Services), including supply chain integrity, ESG practices, labor disputes, and regulatory compliance.
Filter risk signals by topic
Select a theme below to explore the company’s news mentions in specific risk areas.
Recent Articles about Cardinal Health, Inc.
Live alerts from global media, monitored by Business Radar
2024-06-13 (health.com)
FDA Lists 27 Eye Drop Products that May Cause Infections
The FDA is asking consumers to stop using 27 eye drop products over concerns that they're not sterile, and could cause eye infections as a result. CVS Health, Walmart, Target, and other brands were included on in FDA's warning, and one company, Leader (Cardinal Health) has since issued a recall.
Read more
2024-03-03 (fiercebiotech.com)
FDA broadens warnings over recalled Cardinal Health syringes
After giving its most serious rating to Cardinal Health’s syringe recall, the FDA warned healthcare providers that the recall may not go far enough.
Read more
2023-12-19 (fda.gov)
Becton Dickinson (BD)/Carefusion 303 Recalls Alaris Infusion Pumps Due to Compatibility Issues with Cardinal Health Monoject Syringes
BD/Carefusion 303 is recalling their Alaris Infusion Pumps to make a correction on compatibility issues with Cardinal Health Monoject syringes.
Read more
2023-12-11 (endocrinologyadvisor.com)
Compatibility Issues Prompt Recall of Alaris Infusion Pumps
When using the newly branded Cardinal Health Monoject syringes, the pump may refuse to operate or incorrectly estimate the volume of liquid in the syringe.
Read more
2023-12-09 (islandernews.com)
Who can qualify for the 2023 eye drop recall lawsuits
In October, the Food and Drug Administration (FDA) released an updated list of over-the-counter artificial tears products that consumers should not purchase or use.
Read more
2023-12-06 (empr.com)
Compatibility Issues Prompt Recall of Alaris Infusion Pumps
When using the newly branded Cardinal Health Monoject syringes, the pump may refuse to operate or incorrectly estimate the volume of liquid in the syringe.
Read more
2023-12-04 (24x7mag.com)
Becton Dickinson Infusion Pump Recalled for Compatibility Issue
Becton Dickinson is recalling their Alaris Infusion Pumps due to compatibility issues with Cardinal Health Monoject syringes.
Read more
2023-12-03 (devdiscourse.com)
Health News Roundup: AstraZeneca calls off two late-stage potassium drug trials; US FDA gives second approval to Eli Lilly's drug for type of blood cancer and more | Health
The Danish drugmaker is working to convince European governments and insurers to reimburse the drug, seeking to position it as more than a lifestyle drug. EU watchdog seeks more data from GLP-1 drugmakers on suicidal thoughts The EU 's drug watchdog will request more data from makers of a class of
Read more
2023-11-20 (wsau.com)
FDA warns against using Cardinal’s syringes
(Reuters) -The U.S. Food and Drug Administration on Monday warned healthcare providers and facilities not to use Cardinal Health's Monoject syringes w...
Read more
2023-11-14 (ortoday.com)
GlobalData: New smart guidewire for TAVR procedures show promise
U.S.-based Xenter has recently unveiled a new dual-sensor investigational guidewire for use during transcatheter aortic valve replacement (TAVR) procedures. The wireless product poses potential competition to traditional guidewires in the rapidly growing TAVR market, which
Read more
2023-11-14 (ortoday.com)
FDA Grants KATE AI Breakthrough Device Designation for Early Sepsis Detection
Mednition, a leader in clinical artificial intelligence (AI) health care solutions, has announced that KATE Sepsis has received Breakthrough Device Designation from the FDA, recognizing the AI-powered solution as a significant advancement in the early detection of sepsis.
Read more
2023-11-14 (healthexec.com)
FDA announces recall of more than 32 million disposable syringes
The new-look syringes are causing significant issues when used with syringe infusion pumps. This is a Class I recall, which means the FDA believes the products “may cause serious injuries or death.”
Read more